A Study of CX2101A Enteric-Coated Tablets in Healthy Chinese Adult Subjects
Status:
COMPLETED
Trial end date:
2023-03-27
Target enrollment:
Participant gender:
Summary
This study is divided into two parts, including Part I: a randomized, open-label, positive drug-controlled, single ascending dose (SAD) study, a food effect (FE) study, and Part II: a randomized, double-blind, placebo-controlled, multiple ascending dose (MAD) study.